MedPath

Evaluation of effectiveness of a lab test in detecting diseases of middle layer of eye

Not Applicable
Conditions
Health Condition 1: H200- Acute and subacute iridocyclitis
Registration Number
CTRI/2021/02/031276
Lead Sponsor
Aravind Eye Hospital Pondicherry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients attending the uvea clinic who are newly diagnosed with acute uveitis who are willing to undergo the test at the reference laboratory attached to Aravind Eye hospital, Pondicherry

Chronic uveitis patients presenting with reactivation of the disease

Patients of age 18 years and above

Exclusion Criteria

Patients with history of trauma

Chronic uveitis patients with inactive disease

Patients in the pediatric age groups

Immunosuppressed patients

Patients who are already on ACE inhibitors oral steroids or immunosuppressants

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of raised S.ACE levels (52IU/L) among patients with active uveitis <br/ ><br> <br/ ><br>Estimated values of Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value of serum ACE investigation in different etiologies of uveitis including ocular TB and Ocular Sarcoidosis by employing different cut-off values <br/ ><br>Timepoint: At 1 year
Secondary Outcome Measures
NameTimeMethod
Percentage of positive Mantoux test value of more than 10mm and estimated values of Sensitivity, Specificity, Positive Predictive value and Negative Predictive Value of Mantoux test in Ocular TB and Ocular Sarcoidosis <br/ ><br> <br/ ><br>Percentage of occurrence of lymphopenia and estimated values of Sensitivity, Specificity, Positive Predictive value and Negative Predictive value of lymphopenia in Ocular TB and Ocular Sarcoidosis <br/ ><br>Timepoint: At Baseline (Day 0)
© Copyright 2025. All Rights Reserved by MedPath